MedPath

Hangzhou Dinova EP Technology Co.,Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:1
Completed:1

Trial Phases

1 Phases

Not Applicable:6

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (100.0%)

Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation

Not Applicable
Recruiting
Conditions
Atrial Fibrillation (AF)
First Posted Date
2025-06-25
Last Posted Date
2025-06-25
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
292
Registration Number
NCT07036965
Locations
🇨🇳

Ningbo First Hospital, Hangzhou, China

An Exploratory Study of Focal Pulse Ablation System in the Treatment of Atrial Arrhythmia

Not Applicable
Recruiting
Conditions
Atrial Fibrillation (AF)
Typical Atrial Flutter
First Posted Date
2023-12-05
Last Posted Date
2025-02-11
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
10
Registration Number
NCT06157437
Locations
🇨🇳

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder

Not Applicable
Active, not recruiting
Conditions
Atrial Fibrillation
First Posted Date
2023-06-22
Last Posted Date
2023-06-27
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
163
Registration Number
NCT05911685
Locations
🇨🇳

General Hospital of the Northern Theater of the Chinese People's Liberation Army, Shengyang, China

First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder

Not Applicable
Recruiting
Conditions
Nonvalvular Atrial Fibrillation
First Posted Date
2023-02-16
Last Posted Date
2024-01-17
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
10
Registration Number
NCT05731882
Locations
🇨🇳

Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

🇨🇳

Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China

🇨🇳

General Hospital of Northern Theater Command, Shenyang, Liaoning, China

Study on the Safety and Effectiveness of the SnowyTM PFO Closure System

Not Applicable
Not yet recruiting
Conditions
Patent Foramen Ovale
First Posted Date
2022-05-04
Last Posted Date
2023-06-07
Lead Sponsor
Hangzhou Dinova EP Technology Co., Ltd
Target Recruit Count
242
Registration Number
NCT05360771
Locations
🇨🇳

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.